Immunohistochemical staining of tumor tissues has shown that AXL, GAS6 and HIF-1 are coexpressed, supporting the concept that hypoxia and HIF activity is a mechanism for AXL upregulation in human cancers [42,43]. This evidence concerns the gene GAS6 and neoplasm.